WO2012045019A9 - Brca deficiency and methods of use - Google Patents

Brca deficiency and methods of use Download PDF

Info

Publication number
WO2012045019A9
WO2012045019A9 PCT/US2011/054369 US2011054369W WO2012045019A9 WO 2012045019 A9 WO2012045019 A9 WO 2012045019A9 US 2011054369 W US2011054369 W US 2011054369W WO 2012045019 A9 WO2012045019 A9 WO 2012045019A9
Authority
WO
WIPO (PCT)
Prior art keywords
methods
brca deficiency
brca
deficiency
Prior art date
Application number
PCT/US2011/054369
Other languages
French (fr)
Other versions
WO2012045019A2 (en
Inventor
Kirsten Timms
Darl Flake
Jennifer Potter
Jerry Lanchbury
Original Assignee
Myriad Genetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics, Inc. filed Critical Myriad Genetics, Inc.
Priority to CA2813257A priority Critical patent/CA2813257A1/en
Publication of WO2012045019A2 publication Critical patent/WO2012045019A2/en
Publication of WO2012045019A9 publication Critical patent/WO2012045019A9/en
Priority to US13/852,129 priority patent/US20140024028A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
PCT/US2011/054369 2010-10-01 2011-09-30 Brca deficiency and methods of use WO2012045019A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2813257A CA2813257A1 (en) 2010-10-01 2011-09-30 Brca deficiency and methods of use
US13/852,129 US20140024028A1 (en) 2011-09-30 2013-03-28 Brca deficiency and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38869210P 2010-10-01 2010-10-01
US61/388,692 2010-10-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/852,129 Continuation US20140024028A1 (en) 2011-09-30 2013-03-28 Brca deficiency and methods of use

Publications (2)

Publication Number Publication Date
WO2012045019A2 WO2012045019A2 (en) 2012-04-05
WO2012045019A9 true WO2012045019A9 (en) 2012-07-19

Family

ID=45893782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/054369 WO2012045019A2 (en) 2010-10-01 2011-09-30 Brca deficiency and methods of use

Country Status (2)

Country Link
CA (1) CA2813257A1 (en)
WO (1) WO2012045019A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2669682B1 (en) * 2012-05-31 2017-04-19 Heinrich-Heine-Universität Düsseldorf Novel prognostic and predictive biomarkers (tumor markers) for human breast cancer
CN105793437B (en) * 2013-09-23 2020-12-15 芝加哥大学 Methods and compositions relating to DNA damaging agents for cancer treatment
US20170058351A1 (en) * 2013-11-28 2017-03-02 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Methods for Molecular Classification of BRCA-Like Breast and/or Ovarian Cancer

Also Published As

Publication number Publication date
WO2012045019A2 (en) 2012-04-05
CA2813257A1 (en) 2012-04-05

Similar Documents

Publication Publication Date Title
HK1243417A1 (en) Pyridone and aza-pyridone compounds and methods of use
EP2616442B8 (en) Inhibitors of pi3k-delta and methods of their use and manufacture
EP2536283B8 (en) Phenyl-heteroaryl derivatives and methods of use thereof
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
EP2539473B8 (en) Modified proteins and methods of making and using same
EP2552328A4 (en) Expandable devices and methods of use
EP2603201A4 (en) Liposome compositions and methods of use thereof
EP2536756A4 (en) Hsa-related compositions and methods of use
EP2584897A4 (en) Resveratrol-containing compositions and methods of use
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2521922A4 (en) Current sensing devices and methods
EP2539005A4 (en) Mouthpiece and methods of use of same
EP2571421A4 (en) Detection devices and related methods of use
IL225869A (en) Coelenterazine derivatives and methods of using same
EP2579831A4 (en) Dispenser and methods of use
EP2593571A4 (en) Sweetener compositions and methods of making same
IL222969A0 (en) Sweetener compositions and methods of preparing the same
EP2538849A4 (en) Surgical articles and methods
EP2595695A4 (en) Graft devices and methods of use
IL229968A0 (en) Tetrazolyloxime derivatives and methods of producing same
EP2525651A4 (en) Novel centromeres and methods of using the same
WO2011153429A9 (en) Methods of treatment
EP2611791A4 (en) Oligooxopiperazines and methods of making and using them
EP2659528A4 (en) Perylene-based semiconductors and methods of preparation and use thereof
EP2612298A4 (en) Co-compression and co-decompression of data values

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11830024

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2813257

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11830024

Country of ref document: EP

Kind code of ref document: A2